Abstract
Trifolitoxin (TFX, C41H63N15O15S) is a selective, ribosomally-synthesized, post-translationally modified, peptide antibiotic, produced by Rhizobium leguminosarum bv. trifolii T24. TFX specifically inhibits α-proteobacteria, including the plant symbiont Rhizobium spp., the plant pathogen Agrobacterium spp. and the animal pathogen Brucella abortus. TFX-producing strains prevent legume root nodulation by TFX-sensitive rhizobia. TFX has been isolated as a pair of geometric isomers, TFX1 and TFX2, which are derived from the biologically inactive primary amino acid sequence: Asp-Ile-Gly-Gly-Ser-Arg-Gln-Gly-Cys-Val-Ala. Gly-Cys is present as a thiazoline ring and the Arg-Gln-Gly sequence is extensively modified to a UV absorbing, blue fluorescent chromophore. The chromophore consists of a conjugated, 5-membered heterocyclic ring and side chain of modified glutamine.
Cite
CITATION STYLE
Lethbridge, B. J., Asenstorfer, R. E., Bailey, L. S., Breil, B. T., Johnson, J. V., Jones, G. P., … Triplett, E. W. (2022). Post translational modifications of Trifolitoxin: a blue fluorescent peptide antibiotic. Journal of Antibiotics, 75(3), 125–135. https://doi.org/10.1038/s41429-021-00497-0
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.